ArticleCancer medicine2021

PD-L1, PARP1, and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer.

Xiaoyu Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.